Weighted Average Number of Shares Outstanding, Basic of Citius Pharmaceuticals, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Citius Pharmaceuticals, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Citius Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 21,495,274, a 187% increase year-over-year.
  • Citius Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 11,065,225, a 64% increase from 2024.
  • Citius Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 6,726,999, a 11% increase from 2023.
  • Citius Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 6,051,789, a 96% decline from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Citius Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 21,495,274 +14,002,814 +187% 01 Oct 2025 31 Dec 2025 10-Q 13 Feb 2026 2026 Q1
Q3 2025 11,065,225 +4,338,226 +64% 01 Jul 2025 30 Sep 2025 10-K 23 Dec 2025 2025 FY
Q2 2025 11,006,896 +4,052,618 +58% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q3
Q1 2025 8,581,207 +2,218,317 +35% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 7,492,460 +1,134,223 +18% 01 Oct 2024 31 Dec 2024 10-Q 13 Feb 2026 2026 Q1
Q3 2024 6,726,999 +675,210 +11% 01 Jul 2024 30 Sep 2024 10-K 23 Dec 2025 2025 FY
Q2 2024 6,954,278 -146,821,102 -95% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q3
Q1 2024 6,362,890 -139,889,055 -96% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q2
Q4 2023 6,358,237 -139,852,893 -96% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025 2025 Q1
Q3 2023 6,051,789 -140,030,610 -96% 01 Jul 2023 30 Sep 2023 10-K 27 Dec 2024 2024 FY
Q2 2023 153,775,380 +7,645,750 +5.2% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q3
Q1 2023 146,251,945 +210,093 +0.14% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q2
Q4 2022 146,211,130 +198,961 +0.14% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q1
Q3 2022 146,082,399 01 Jul 2022 30 Sep 2022 10-K 29 Dec 2023 2023 FY
Q2 2022 146,129,630 +8,978,361 +6.5% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q3
Q1 2022 146,041,852 +50,044,425 +52% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q2
Q4 2021 146,012,169 01 Oct 2021 31 Dec 2021 10-Q 10 Feb 2023 2023 Q1
Q2 2021 137,151,269 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q3
Q1 2021 95,997,427 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q2
Q2 2014 18,000,000 0 0% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2014 2014 Q3
Q1 2014 18,000,000 0 0% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2014 2014 Q2
Q4 2013 18,000,000 0 0% 01 Oct 2013 31 Dec 2013 10-Q 19 Feb 2014 2014 Q1
Q3 2013 18,000,000 0 0% 01 Jul 2013 30 Sep 2013 10-K 06 Feb 2014 2013 FY
Q2 2013 18,000,000 0 0% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014 2014 Q3
Q1 2013 18,000,000 0 0% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q2
Q4 2012 18,000,000 0 0% 01 Oct 2012 31 Dec 2012 10-Q 19 Feb 2014 2014 Q1
Q3 2012 18,000,000 0 0% 01 Jul 2012 30 Sep 2012 10-K 06 Feb 2014 2013 FY
Q2 2012 18,000,000 0 0% 01 Apr 2012 30 Jun 2012 10-Q 18 Sep 2013 2013 Q3
Q1 2012 18,000,000 0 0% 01 Jan 2012 31 Mar 2012 10-Q 13 May 2013 2013 Q2
Q4 2011 18,000,000 0 0% 01 Oct 2011 31 Dec 2011 10-Q 08 Feb 2013 2013 Q1
Q3 2011 18,000,000 01 Jul 2011 30 Sep 2011 10-K 15 Jan 2013 2012 FY
Q2 2011 18,000,000 01 Apr 2011 30 Jun 2011 10-Q 17 Aug 2012 2012 Q3
Q1 2011 18,000,000 01 Jan 2011 31 Mar 2011 10-Q 11 May 2012 2012 Q2
Q4 2010 18,000,000 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012 2012 Q1

Citius Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 11,065,225 +4,338,226 +64% 01 Oct 2024 30 Sep 2025 10-K 23 Dec 2025 2025 FY
2024 6,726,999 +675,210 +11% 01 Oct 2023 30 Sep 2024 10-K 23 Dec 2025 2025 FY
2023 6,051,789 -140,030,610 -96% 01 Oct 2022 30 Sep 2023 10-K 27 Dec 2024 2024 FY
2022 146,082,399 +37,483,319 +35% 01 Oct 2021 30 Sep 2022 10-K 29 Dec 2023 2023 FY
2021 108,599,080 01 Oct 2020 30 Sep 2021 10-K 22 Dec 2022 2022 FY
2013 18,000,000 0 0% 01 Oct 2012 30 Sep 2013 10-K 06 Feb 2014 2013 FY
2012 18,000,000 0 0% 01 Oct 2011 30 Sep 2012 10-K 06 Feb 2014 2013 FY
2011 18,000,000 01 Oct 2010 30 Sep 2011 10-K 15 Jan 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.